Recordati H1 FY26 net income rises 24.8% to € 269.7 million; revenue increases 6.6% to € 1.41 billion

Reuters2026/07/28 15:50

By:Reuters

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Recordati first-half 2026 net revenue rose 6.6% to € 1.41 billion; IFRS net income climbed 24.8% to € 269.7 million.
EBITDA increased 8.8% to € 540.2 million, lifting the margin to 38.3%.
Rare Diseases revenue grew 17.1% to € 603.9 million, driven by Isturisa revenue up 58.0% to € 178.8 million.
Free cash flow improved to € 299.4 million; net debt fell to € 1.92 billion, with leverage below 1.9x EBITDA.
CEO Rob Koremans flagged stepped-up investment for Isturisa’s U.S. expansion; full-year 2026 targets were confirmed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Recordati Industria Chimica e Farmaceutica S.p.A. published the original content used to generate this news brief via SDIR, the Italian regulatory disclosure system (Ref. ID: 216_170261_2026_oneinfo.pdf), on July 28, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Recordati H1 FY26 net income rises 24.8% to € 269.7 million; revenue increases 6.6% to € 1.41 billion

You may also like

Crypto prices